Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2024

13-11-2023 | Care | Pancreatic Tumors

Association of Inpatient Palliative Care Consultation with Clinical and Financial Outcomes for Pancreatic Cancer

Authors: Shineui Kim, BA, Nikhil Chervu, MS, MD, Alykhan Premji, MD, Saad Mallick, MD, Arjun Verma, BS, Konmal Ali, Peyman Benharash, MD, Timothy Donahue, MD

Published in: Annals of Surgical Oncology | Issue 2/2024

Login to get access

Abstract

Background

Palliative care consultation (PCC) has been shown to improve quality of life and reduce costs for various chronic life-threatening diseases. Despite PCC incorporation into modern pancreatic cancer care guidelines, limited data regarding its specific utilization and impact on resource use is available.

Methods

The 2016–2020 Nationwide Readmissions Database was used to identify all adult hospitalizations entailing pancreatic cancer. Only patients with at least one readmission within 90 days were included to account for uncaptured out-of-hospital mortality. Multivariable regression models were used to ascertain the relationship between inpatient PCC during initial hospitalization and index as well as cumulative costs, overall length of stay (LOS), readmission rate, and number of repeat hospitalizations.

Results

Of an estimated 175,805 patients with pancreatic cancer, 11.1% had inpatient PCC during the index admission. PCC utilization significantly increased from 10.5% in 2016 to 11.6% in 2020 (nptrend < 0.001). After adjustment, PCC was associated with reduced index hospitalization costs [β: − $1100; 95% confidence interval (CI) − 1500, − 800; P < 0.001] and cumulative 90-day costs (β: − $11,700; 95% CI − 12,700, − 10,000; P < 0.001). PCC was associated with longer index LOS (β: + 1.12 days, 95% CI 0.92–1.31, P < 0.001) but significantly reduced cumulative LOS (β: − 3.16 days; 95% CI − 3.67, − 2.65; P < 0.001). Finally, PCC was linked with decreased odds of 30-day nonelective readmission (AOR: 0.48, 95% CI 0.45–0.50, P < 0.001).

Discussion

PCC was associated with decreased costs, readmission rates, and number of hospitalizations among patients with pancreatic cancer. Directed strategies to increase utilization and reduce barriers to consultation should be implemented to encourage practitioners to maximize inpatient PCC referral rates.
Appendix
Available only for authorised users
Literature
21.
go back to reference Davis MP, Temel JS, Balboni T, Glare P. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med. 2015;4(3):99–121.PubMed Davis MP, Temel JS, Balboni T, Glare P. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med. 2015;4(3):99–121.PubMed
27.
go back to reference Hwang J, Shen J, Kim SJ, et al. Ten-year trends of utilization of palliative care services and life-sustaining treatments and hospital costs associated with patients with terminally ill lung cancer in the United States from 2005 to 2014. Am J Hosp Palliat Med. 2019;36(12):1105–13. https://doi.org/10.1177/1049909119852082.CrossRef Hwang J, Shen J, Kim SJ, et al. Ten-year trends of utilization of palliative care services and life-sustaining treatments and hospital costs associated with patients with terminally ill lung cancer in the United States from 2005 to 2014. Am J Hosp Palliat Med. 2019;36(12):1105–13. https://​doi.​org/​10.​1177/​1049909119852082​.CrossRef
30.
go back to reference van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–33.CrossRefPubMed van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–33.CrossRefPubMed
Metadata
Title
Association of Inpatient Palliative Care Consultation with Clinical and Financial Outcomes for Pancreatic Cancer
Authors
Shineui Kim, BA
Nikhil Chervu, MS, MD
Alykhan Premji, MD
Saad Mallick, MD
Arjun Verma, BS
Konmal Ali
Peyman Benharash, MD
Timothy Donahue, MD
Publication date
13-11-2023
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-14528-7

Other articles of this Issue 2/2024

Annals of Surgical Oncology 2/2024 Go to the issue